Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kennedy

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer|May 17, 2021
Racial differences in the treatment and outcomes for prostate cancer in MassachusettsAlexander P Cole, Peter Herzog, Hari S Iyer, et al.
Malaria Journal|December 19, 2012
A rapid and scalable density gradient purification method for Plasmodium sporozoitesMark Kennedy, Matthew E Fishbaugher, Ashley M Vaughan, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agentsWenlin Huang, Matthew A Hulverson, Zhongsheng Zhang, et al.
Open Heart|March 31, 2026
Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarctionJack Laffan, Huixuan Gao, Andrew Street, et al.
Plos One|September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor originRyan Woodhouse, Meijuan Li, Jason Hughes, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.
Nature Medicine|March 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancerZoe June F Assaf, Wei Zou, Alexander D Fine, et al.
BMJ Open|July 19, 2018
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practiceJohn Furler, David Norman O'Neal, Jane Speight, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trialJohn Furler, David O'Neal, Jane Speight, et al.
Scientific Reports|January 31, 2025
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indicationsColin D Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer|May 17, 2021
Racial differences in the treatment and outcomes for prostate cancer in MassachusettsAlexander P Cole, Peter Herzog, Hari S Iyer, et al.
Malaria Journal|December 19, 2012
A rapid and scalable density gradient purification method for Plasmodium sporozoitesMark Kennedy, Matthew E Fishbaugher, Ashley M Vaughan, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2016
5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agentsWenlin Huang, Matthew A Hulverson, Zhongsheng Zhang, et al.
Open Heart|March 31, 2026
Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarctionJack Laffan, Huixuan Gao, Andrew Street, et al.
Plos One|September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor originRyan Woodhouse, Meijuan Li, Jason Hughes, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.
Nature Medicine|March 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancerZoe June F Assaf, Wei Zou, Alexander D Fine, et al.
BMJ Open|July 19, 2018
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practiceJohn Furler, David Norman O'Neal, Jane Speight, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trialJohn Furler, David O'Neal, Jane Speight, et al.
Scientific Reports|January 31, 2025
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indicationsColin D Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Pageof 7